RESUMO
BACKGROUND: Neuroactive steroids (NAS) are derivatives of cholesterol or steroidal precursors made in the gonads, adrenal gland, placenta and brain. We characterized longitudinal plasma proneuroactive and NAS in healthy perinatal comparison women (HPCW), women at-risk for perinatal depression (AR-PND), and women with PND with/without comorbid anxiety. We hypothesized that AR-PND women who either did or did not go on to develop PND would have elevated NAS concentrations as compared to HPCW and that NAS would be correlated to depressive and anxiety symptoms. METHODS: A prospective cohort study evaluated 75 medication-free perinatal women (HPCW, n = 30; AR-PND, n = 19; PND, n = 26). Standardized depression and anxiety assessments and blood samples were completed across 5 visits. Structured Clinical Interviews for DSM-IV TR Disorders were administered at study entry and exit. Plasma pregnenolone, progesterone, 5α- and 5ß-dihydroprogesterone, pregnanolone, allopregnanolone, deoxycorticosterone and tetrahydrodeoxycorticosterone were quantified by liquid chromatography-tandem mass spectrometry. Longitudinal relationships between risk-group, depression and anxiety symptoms, and NAS concentrations were analyzed using generalized estimating equations to control for repeated measures correlations. RESULTS: Perinatal 5α-dihydroprogesterone, 5ß-dihydroprogesterone, allopregnanolone, deoxycorticosterone, and tetrahydrodeoxycorticosterone concentrations were higher in AR-PND and PND women compared to HPCW (ß = 3.57 ± 1.40 and ß = 2.11 ± 1.12, p = 0.03; ß = 0.18 ± 0.06 and ß = 0.03 ± 0.05, p = 0.02; ß = 1.06 ± 0.42 and ß = 1.19 ± 0.47, p = 0.01; ß = 0.17 ± 0.07 and ß = 0.11 ± 0.06, p = 0.05; ß = 0.03 ± 0.01 and ß = 0.03 ± 0.01, p = 0.05, respectively). Perinatal allopregnanolone, 5α-dihydroprogesterone and tetrahydrodeoxycorticosterone were positively associated with HAM-D17 (all p < 0.02). HAM-A was positively associated with 5α- and 5ß-dihydroprogesterone, pregnanolone, allopregnanolone, deoxycorticosterone and tetrahydrodeoxycorticosterone (all p < 0.05). A history of depression was associated with increased 5α-dihydroprogesterone (2.20 ± 1.09, p = 0.05), deoxycorticosterone (0.13 ± 0.06, p = 0.03) and tetrahydrodeoxycorticosterone (0.03 ± 0.01, p = 0.02). CONCLUSION: To our knowledge, this study represents the largest prospective study of 5-α and 5-ß reductase products of progesterone and deoxycorticosterone in HPCW and women AR-PND. Data suggest that PND is associated with both a reduction of progesterone to 5ß-dihydroprogesterone, 5α-dihydroprogesterone, and allopregnanolone, and the 21-hydroxylation to deoxycorticosterone and tetrahydrodeoxycorticosterone. The shift towards 5α-dihydroprogesterone, deoxycorticosterone and tetrahydrodeoxycorticosterone was associated with a history of depression, a significant risk factor for PND.
Assuntos
Depressão/metabolismo , Neuroesteroides/análise , Cuidado Pré-Natal/psicologia , 20-alfa-Di-Hidroprogesterona/análise , 20-alfa-Di-Hidroprogesterona/sangue , Adulto , Ansiedade/metabolismo , Ansiedade/fisiopatologia , Cromatografia Líquida/métodos , Depressão/fisiopatologia , Depressão Pós-Parto , Transtorno Depressivo/metabolismo , Transtorno Depressivo/fisiopatologia , Desoxicorticosterona/análogos & derivados , Desoxicorticosterona/análise , Desoxicorticosterona/sangue , Feminino , Humanos , Estudos Longitudinais , Neuroesteroides/sangue , Parto/psicologia , Gravidez , Pregnanolona/análise , Pregnanolona/sangue , Pregnenolona/análise , Pregnenolona/sangue , Cuidado Pré-Natal/métodos , Progesterona/análise , Progesterona/sangue , Estudos Prospectivos , Fatores de Risco , Espectrometria de Massas em Tandem/métodosRESUMO
Both systemic and local production contribute to the concentration of steroids measured in the brain. This idea was originally based on rodent studies and was later extended to other species, including humans and birds. In quail, a widely used model in behavioural neuroendocrinology, it was demonstrated that all enzymes needed to produce sex steroids from cholesterol are expressed and active in the brain, although the actual concentrations of steroids produced were never investigated. We carried out a steroid profiling in multiple brain regions and serum of sexually mature male and female quail by gas chromatography coupled with mass spectrometry. The concentrations of some steroids (eg, corticosterone, progesterone and testosterone) were in equilibrium between the brain and periphery, whereas other steroids (eg, pregnenolone (PREG), 5α/ß-dihydroprogesterone and oestrogens) were more concentrated in the brain. In the brain regions investigated, PREG sulphate, progesterone and oestrogen concentrations were higher in the hypothalamus-preoptic area. Progesterone and its metabolites were more concentrated in the female than the male brain, whereas testosterone, its metabolites and dehydroepiandrosterone were more concentrated in males, suggesting that sex steroids present in quail brain mainly depend on their specific steroidogenic pathways in the ovaries and testes. However, the results of castration experiments suggested that sex steroids could also be produced in the brain independently of the peripheral source. Treatment with testosterone or oestradiol restored the concentrations of most androgens or oestrogens, respectively, although penetration of oestradiol in the brain appeared to be more limited. These studies illustrate the complex interaction between local brain synthesis and the supply from the periphery for the steroids present in the brain that are either directly active or represent the substrate of centrally located enzymes.
Assuntos
Encéfalo/metabolismo , Codorniz/fisiologia , Caracteres Sexuais , Esteroides/sangue , Esteroides/metabolismo , 20-alfa-Di-Hidroprogesterona/sangue , 20-alfa-Di-Hidroprogesterona/metabolismo , 5-alfa-Di-Hidroprogesterona/sangue , 5-alfa-Di-Hidroprogesterona/metabolismo , Animais , Castração , Corticosterona/sangue , Corticosterona/metabolismo , Estrogênios/sangue , Estrogênios/metabolismo , Feminino , Hipotálamo/metabolismo , Masculino , Pregnenolona/sangue , Pregnenolona/metabolismo , Área Pré-Óptica/metabolismo , Testosterona/sangue , Testosterona/metabolismoRESUMO
Neuroactive steroids (NAS) are allosteric modulators of the γ-aminobutyric acid (GABA) system. NAS and GABA are implicated in depression. The peripartum period involves physiologic changes in NAS which may be associated with peripartum depression and anxiety. We measured peripartum plasma NAS and GABA in healthy comparison subjects (HCS) and those at-risk for postpartum depression (AR-PPD) due to current mild depressive or anxiety symptoms or a history of depression. We evaluated 56 peripartum medication-free subjects. We measured symptoms with the Hamilton Depression Rating Scale (HAM-D17), Hamilton Anxiety Rating Scale (HAM-A) and Spielberger State-Trait Anxiety Inventory-State (STAI-S). Plasma NAS and GABA were quantified by liquid chromatography-mass spectrometry. We examined the associations between longitudinal changes in NAS, GABA and depressive and anxiety symptoms using generalized estimating equation methods. Peripartum GABA concentration was 1.9±0.7ng/mL (p=0.004) lower and progesterone and pregnanolone were 15.8±7.5 (p=0.04) and 1.5±0.7ng/mL (p=0.03) higher in AR-PPD versus HCS, respectively. HAM-D17 was negatively associated with GABA (ß=-0.14±0.05, p=0.01) and positively associated with pregnanolone (ß=0.16±0.06, p=0.01). STAI-S was positively associated with pregnanolone (ß=0.11±0.04, p=0.004), allopregnanolone (ß=0.13±0.05, p=0.006) and pregnenolone (ß=0.02±0.01, p=0.04). HAM-A was negatively associated with GABA (ß=-0.12±0.04, p=0.004) and positively associated with pregnanolone (ß=0.11±0.05, p=0.05). Altered peripartum NAS and GABA profiles in AR-PPD women suggest that their interaction may play an important role in the pathophysiology of peripartum depression and anxiety.
Assuntos
Depressão Pós-Parto/sangue , Esteroides/sangue , Ácido gama-Aminobutírico/sangue , 20-alfa-Di-Hidroprogesterona/sangue , Adulto , Estudos de Casos e Controles , Desoxicorticosterona/sangue , Feminino , Humanos , Estudos Longitudinais , Período Periparto/fisiologia , Período Periparto/psicologia , Gravidez , Pregnanolona/sangue , Progesterona/sangue , Receptores de GABA-A/sangue , Fatores de RiscoRESUMO
Observations performed in a subset of patients treated for male pattern hair loss indicate that persistent sexual side effects as well as anxious/depressive symptomatology have been reported even after discontinuation of finasteride treatment. Due to the capability of finasteride to block the metabolism of progesterone (PROG) and/or testosterone (T) we have evaluated, by liquid chromatography-tandem mass spectrometry, the levels of several neuroactive steroids in paired plasma and cerebrospinal fluid (CSF) samples obtained from post-finasteride patients and in healthy controls. At the examination, post-finasteride patients reported muscular stiffness, cramps, tremors and chronic fatigue in the absence of clinical evidence of any muscular disorder or strength reduction. Although severity of the anxious/depressive symptoms was quite variable in their frequency, overall all the subjects had a fairly complex and constant neuropsychiatric pattern. Assessment of neuroactive steroid levels in CSF showed a decrease of PROG and its metabolites, dihydroprogesterone (DHP) and tetrahydroprogesterone (THP), associated with an increase of its precursor pregnenolone (PREG). Altered levels were also observed for T and its metabolites. Thus, a significant decrease of dihydrotestosterone (DHT) associated with an increase of T as well as of 3α-diol was detected. Changes in neuroactive steroid levels also occurred in plasma. An increase of PREG, T, 3α-diol, 3ß-diol and 17ß-estradiol was associated with decreased levels of DHP and THP. The present observations show that altered levels of neuroactive steroids, associated with depression symptoms, are present in androgenic alopecia patients even after discontinuation of the finasteride treatment. This article is part of a Special Issue entitled 'Sex steroids and brain disorders'.
Assuntos
Alopecia/tratamento farmacológico , Depressão/induzido quimicamente , Finasterida/efeitos adversos , Esteroides/sangue , Esteroides/líquido cefalorraquidiano , 20-alfa-Di-Hidroprogesterona/sangue , 20-alfa-Di-Hidroprogesterona/líquido cefalorraquidiano , Adulto , Transtornos de Ansiedade/induzido quimicamente , Transtornos de Ansiedade/metabolismo , Estudos de Casos e Controles , Depressão/sangue , Finasterida/uso terapêutico , Humanos , Masculino , Pregnenolona/sangue , Pregnenolona/líquido cefalorraquidiano , Progesterona/sangue , Progesterona/líquido cefalorraquidiano , Disfunções Sexuais Psicogênicas/sangue , Disfunções Sexuais Psicogênicas/induzido quimicamenteRESUMO
Incidence, progression and severity of the multiple sclerosis, an inflammatory, demyelinating disease of the central nervous system (CNS) are affected in a sex-depending way. Physiological situations characterized by changes in sex steroid plasma levels, such as menstrual cycle, menopause or pregnancy, affect the disease course, suggesting that these molecules might exert a role in this disease. In order to understand better this possible relationship, we have here assessed the levels of neuroactive steroids present in different CNS regions of male and female rats affected by acute experimental autoimmune encephalomyelitis (EAE). In addition, we compared these levels with those present in plasma. Data obtained by liquid chromatography-tandem mass spectrometry indicate that the levels of neuroactive steroids show sex and regional differences in control and EAE nervous system and that a clear difference is also observed between CNS and plasma levels. In particular, among neuroactive steroids here considered, the levels of progesterone metabolites (i.e., dihydroprogesterone, tetrahydroprogesterone and isopregnanolone) and testosterone metabolites (i.e., dihydrotestosterone and 5alpha-androstane-3alpha17beta-diol), show sex dimorphic and region-specific changes in the CNS. Moreover, some changes observed in the CNS were not detected in plasma. These findings might represent an interesting background to design therapies and possibly sex-specific therapies for multiple sclerosis based on neuroactive steroids or synthetic ligands able to interact with classical and non-classical steroid receptors.
Assuntos
Encéfalo/metabolismo , Encefalomielite Autoimune Experimental/sangue , Esclerose Múltipla/sangue , Neurotransmissores/sangue , Caracteres Sexuais , 20-alfa-Di-Hidroprogesterona/sangue , Doença Aguda , Androstano-3,17-diol/sangue , Animais , Encéfalo/anatomia & histologia , Encéfalo/fisiopatologia , Cromatografia Líquida , Di-Hidrotestosterona/sangue , Modelos Animais de Doenças , Encefalomielite Autoimune Experimental/fisiopatologia , Feminino , Masculino , Espectrometria de Massas , Esclerose Múltipla/fisiopatologia , Neurotransmissores/análise , Pregnanolona/sangue , Progesterona/metabolismo , Ratos , Testosterona/metabolismoRESUMO
AIM: To quantify progesterone (P) and one of its metabolites 20alpha-hydroxy-4-pregnen-3-one (20alpha-OHP) in rat plasma and uterus after im administration of progesterone. METHODS: Plasma and uterus samples were prepared by liquid-liquid extraction and separated through Shimadzu VP-ODS column (150 mm x 4.6 mm ID, 5 microm). The mobile phase consisted of acetonitrile and water (60: 40, adjusted to pH 4.0 with phosphoric acid). The detector was set at 240 nm. Norgestrel was used as the internal standard. RESULTS: Cmax of P in plasma was (508 +/- 62) microg x L(-1), Tmax was (3.2 +/- 0.4) h, T1/2 (ke) was (10 +/- 4) h and mean AUC0-48h was (5886 +/- 1573) microg x L(-1) x h. The maximum concentration of P in uterus was (1.7 +/- 1.1) microg x g(-1) and the peak time was (5.2 +/- 1.11) h. 20alpha-OHP showed a similar Tmax with P. CONCLUSION: The method is accurate and convenient. It can be used to determine P and its main metabolite 20alpha-OHP simultaneously for studying their preclinical pharmacokinetics.
Assuntos
20-alfa-Di-Hidroprogesterona/farmacocinética , Progesterona/farmacocinética , Útero/metabolismo , 20-alfa-Di-Hidroprogesterona/sangue , Animais , Área Sob a Curva , Cromatografia Líquida de Alta Pressão/métodos , Feminino , Injeções Intramusculares , Progesterona/sangue , Progesterona/metabolismo , Ratos , Ratos WistarRESUMO
The mechanisms that mediate the cardioprotective action of steroid hormones in postmenopausal women are poorly understood. To study the inter-relationship between female steroid hormones and cardiac natriuretic peptides, plasma levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) were measured in postmenopausal women, both before and after oestrogen replacement therapy. A total of 22 healthy postmenopausal women (mean age 51.9+/-4.6 years) were enrolled in the study; all had been postmenopausal for at least 1 year and all reported climacteric symptoms accompanied by increased levels of follicle-stimulating hormone (>30 m-i.u./ml) and luteinizing hormone (>20 m-i.u./ml), and a reduction in oestradiol (<25 pg/ml). All women were given hormone replacement therapy with transdermal oestradiol, either patch (50 microg/24 h) or gel (1 mg/day), cyclically combined with oral dihydrogesterone (10 mg/day for 12 days/month, on days 19-30 of the month). ANP and BNP were measured directly in plasma samples with specific and sensitive immunoradiometric assays before and after hormone replacement therapy (transdermal oestradiol combined with oral dihydrogesterone). Body weight, arterial blood pressure and echocardiographic examination values did not change after hormone replacement therapy. As expected, serum oestradiol increased significantly and gonadotropins decreased as an effect of the hormone replacement therapy. On average, both ANP and BNP had increased significantly after 3 months of hormone replacement therapy [ANP: before treatment, 17.6+/-9.6 pg/ml; after, 23.6+/-5.6 pg/ml (P=0.0173); BNP: before treatment, 12.6+/-10.2 pg/ml; after, 19.8+/-14.0 pg/ml (P<0.0001)]. Our study indicates that hormone replacement therapy for a period of 3 months induces a rise in the circulating levels of cardiac natriuretic hormones in postmenopausal women. Our data also suggest the working hypothesis that cardiac natriuretic peptides may play an important role in mediating the cardioprotective effects of female steroid sex hormones in women throughout life.
Assuntos
Fator Natriurético Atrial/sangue , Terapia de Reposição de Estrogênios/métodos , Peptídeo Natriurético Encefálico/sangue , Pós-Menopausa/efeitos dos fármacos , 20-alfa-Di-Hidroprogesterona/sangue , 20-alfa-Di-Hidroprogesterona/uso terapêutico , Administração Cutânea , Análise de Variância , Estradiol/sangue , Estradiol/uso terapêutico , Feminino , Humanos , Ensaio Imunorradiométrico , Medições Luminescentes , Pessoa de Meia-Idade , Pós-Menopausa/sangueRESUMO
In 17beta-estradiol (E)-treated ovariectomized (OVX) rabbits, the coitus-induced luteinizing hormone (LH) surge is only one fourth that in ovarian-intact rabbits. In this study, we determined the pattern of the coitus-induced gonadotropin release, i.e., LH and follicle-stimulating hormone (FSH), in OVX + E animals without or with continuous 3-wk treatment of 20-alphahydroxypregn-4-en-3-one (20alphaP). For positive and negative experimental controls, ovarian-intact rabbits were either mated or sham mated, respectively. The pituitary hormones prolactin (PRL) and growth hormone (GH) were measured to serve as collateral controls for gonadotropins. The addition of continuous 20alphaP in OVX + E does fail to stimulate a coitus-induced LH surge equal in magnitude and duration to the LH surge in ovarian-intact rabbits. Postcoital levels of FSH were greater in OVX + E + 20alphaP animals than those in OVX + E rabbits. Coitus induced a PRL surge in ovarian-intact and OVX + steroid-treated females, but not in mated males, thereby suggesting a gender difference in this neuroendocrine circuit. Neither coitus nor steroids altered plasma GH values in female or male animals. We conclude that chronic administration of neither E nor E + 20alphaP can restore full-scale gonadotropin surges in OVX rabbits, whereas replacement of one or both of these steroids is sufficient for a coitus-induced PRL surge. Moreover, the presented observation that activin stimulates hypothalamic gonadotropin-releasing hormone (GnRH) release suggests a possible involvement of ovarian proteins in the production of a full-scale coitus-induced GnRH/LH surge.
Assuntos
Hormônio Foliculoestimulante/metabolismo , Hormônio Luteinizante/metabolismo , Ovário/fisiologia , Prolactina/metabolismo , 20-alfa-Di-Hidroprogesterona/sangue , 20-alfa-Di-Hidroprogesterona/farmacologia , Ativinas , Animais , Núcleo Arqueado do Hipotálamo/efeitos dos fármacos , Copulação/fisiologia , Estradiol/sangue , Estradiol/farmacologia , Feminino , Hormônio Foliculoestimulante/sangue , Hormônio Liberador de Gonadotropina/metabolismo , Hormônio do Crescimento/sangue , Inibinas/administração & dosagem , Hormônio Luteinizante/sangue , Masculino , Eminência Mediana/efeitos dos fármacos , Ovariectomia , Prolactina/sangue , CoelhosRESUMO
We investigated whether prolactin (PRL) treatments resembling the intermittent PRL surges of estrous cycles could induce luteal regression in hypophysectomized rats. Immature female rats were stimulated to ovulate and form corpora lutea with exogenous gonadotropins, and were hypophysectomized following ovulation. A single s.c. injection of either vehicle (VEH) or PRL was administered to each rat on post-hypophysectomy Day 8 and again on Day 11. The four resulting treatment groups consisted of rats that received two injections of VEH, VEH followed by PRL, PRL followed by VEH, or two injections of PRL. Rats were killed 24 or 72 h following the second injection. Plasma 20alpha-dihydroprogesterone, luteal weight, and total luteal protein were determined. One ovary was sectioned for immunohistochemistry for monocytes/macrophages, apoptotic nuclei, and major histocompatibility class II (MHC II) molecules. No effect of time (following injection) was observed on any endpoint, indicating that PRL does not have an ongoing regressive action. Time groups from within each treatment group were therefore pooled for analysis. Significant declines (P: < 0.05) in plasma concentrations of 20alpha-dihydroprogesterone, luteal weight, and protein per corpus luteum occurred only after two injections of PRL. Numbers of luteal monocytes/macrophages, apoptotic nuclei, and MHC II-positive cells were low in all groups; numbers of luteal monocytes/macrophages increased following two injections of PRL (P: < 0.05). We conclude that PRL has a cumulative regressive effect on the corpus luteum of the hypophysectomized rat. Drawing a parallel with the estrous cycle, we suggest that continued exposure to PRL, over several cycles, is necessary to induce full luteal regression.
Assuntos
Corpo Lúteo/efeitos dos fármacos , Hipofisectomia , Prolactina/farmacologia , 20-alfa-Di-Hidroprogesterona/sangue , Animais , Apoptose/efeitos dos fármacos , Corpo Lúteo/citologia , Corpo Lúteo/fisiologia , Feminino , Antígenos de Histocompatibilidade Classe II/metabolismo , Macrófagos/efeitos dos fármacos , Monócitos/efeitos dos fármacos , Tamanho do Órgão/efeitos dos fármacos , Prolactina/administração & dosagem , Proteínas/efeitos dos fármacos , Proteínas/metabolismo , Ratos , Ratos Sprague-DawleyRESUMO
OBJECTIVE: Prolactin is capable of both trophic and lytic actions in rat corpora lutea. In corpora lutea responding to a trophic prolactin signal, the long form of the prolactin receptor is the dominant form and is upregulated by prolactin. We investigated whether mRNA for the short form of the prolactin receptor was dominant in corpora lutea responding to a lytic prolactin signal, and whether the relative concentrations of the mRNAs for both forms of the prolactin receptor were changed during this response. DESIGN AND METHODS: Immature rats were ovulated by injection of 5 IU equine chorionic gonadotrophin and 5 IU human chorionic gonadotrophin, and were hypophysectomized shortly after ovulation. Nine days after hypophysectomy, rats were injected with prolactin (500 microg/day) or vehicle for 24 (n=6, n=6) or 72 h (n=13, n=5). Total RNA was isolated from corpora lutea and mRNA for both types of prolactin receptor were analyzed by semiquantitative RT-PCR using the ribosomal protein S16 as the internal control. RESULTS: The intensities of the long- and short-form prolactin receptor signals were normalized to the S16 internal control and expressed as relative densitometric units. The normalized values at 24h for prolactin-treated vs vehicle-treated rats were 0.23 +/- 0.05 vs 0.49 +/- 0.15 (P>0.05) for the short form and 4.04 +/- 0.8 vs 4.23 +/- 0. 6 (P>0.05) for the long form. The values for 72 h were 0.30 +/- 0.05 vs 0.24 +/- 0.05 (P>0.05) for the short form and 2.76 +/- 0.4 vs 5. 53 +/- 0.3 (P<0.01) for the long form respectively. CONCLUSION: The long form of the prolactin receptor is the dominant form at both time-points; however, the concentration of mRNA for this receptor isoform was specifically downregulated by prolactin treatment. Our results suggest that the short form of the prolactin receptor alone is unlikely to mediate the luteolytic action of prolactin, but that luteolytic events may be influenced via a change in the ratio of the two receptor isoforms.
Assuntos
Regulação da Expressão Gênica/efeitos dos fármacos , Luteólise/efeitos dos fármacos , Prolactina/farmacologia , RNA Mensageiro/metabolismo , Receptores da Prolactina/genética , 20-alfa-Di-Hidroprogesterona/sangue , Animais , Gonadotropina Coriônica/administração & dosagem , Gonadotropina Coriônica/farmacologia , Corpo Lúteo/anatomia & histologia , Feminino , Hipofisectomia , Tamanho do Órgão , Indução da Ovulação , Ratos , Ratos Sprague-Dawley , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
We measured ovarian lipid peroxide (LP) levels and plasma progestins, progesterone (P4) and 20alpha-dihydroprogesterone, throughout pseudopregnancy in gonadotropin-primed immature rats. Plasma P4 fluctuated, with two peaks on days 5 (PSP5) and 8 of pseudopregnancy, and then declined to the basal level by PSP12. Ovarian LP increased from PSP1 to PSP4, decreased temporarily until PSP8, and then rose gradually until PSP14. From PSP1 through PSP7, ovarian LP was positively correlated with total progestins according to the Spearman ranked correlation coefficient (r=+0.829, p<0.05). In contrast, a negative correlation between ovarian LP and plasma P4 was apparent (r=-0.816, p<0.05) from PSP8 to PSP14. These results show the biphasic correlation of LP with luteal progestational activity depending on the luteal stage.
Assuntos
Peróxidos Lipídicos/fisiologia , Ovário/fisiologia , Progestinas/sangue , Pseudogravidez/veterinária , 20-alfa-Di-Hidroprogesterona/sangue , Animais , Gonadotropina Coriônica/fisiologia , Feminino , Peróxidos Lipídicos/análise , Fase Luteal/fisiologia , Malondialdeído/análise , Ovulação , Gravidez , Progesterona/sangue , Pseudogravidez/fisiopatologia , Radioimunoensaio/veterinária , Ratos , Ratos Wistar , Estatísticas não ParamétricasRESUMO
Previous studies in the placental viviparous bonnethead shark, Sphyrna tiburo, have correlated 17 beta-estradiol, progesterone, testosterone, and dihydrotestosterone with reproductive events in both males and females. However, several key reproductive events, including implantation, maintenance of pregnancy, and parturition, did not correlate with these four steroid hormones. Therefore, the present study investigated three steroid hormones, 11-ketotestosterone, 11-ketoandrostenedione, and dihydroprogesterone, which have demonstrably important roles in the reproductive cycles of teleosts. It was hypothesized that one or more of these three hormones would correlate with specific reproductive events in S. tiburo. Concurrently, developmental (growth and/or maturation) analyses of these three steroids plus 17 beta-estradiol, progesterone, testosterone, and dihydrotestosterone were investigated in juvenile bonnethead sharks. Serum dihydroprogesterone concentrations were highest in mature females and 11-ketotestosterone concentrations were highest in mature males. In mature females, 11-ketoandrostenedione levels were elevated from the time of mating, through six months of sperm storage and another four months of gestation. At parturition concentrations became significantly lower and remained lower until mating occurred again in another two to three months. Serum 11-ketotestosterone concentrations were the highest at implantation though not significant. In mature males, significantly elevated serum levels of dihydroprogesterone occurred in April and May, near the start of annual testicular development. During growth in males, testosterone and dihydrotestosterone increased progressively and in females, testosterone increased progressively. At maturity in males, significant increases occurred in testosterone and 11-ketotestosterone concentrations while, in females, dihydroprogesterone, 11-ketotestosterone, 17 beta-estradiol, progesterone, testosterone, and dihydrotestosterone concentrations increased. This study shows that although testosterone may be the primary androgen in the bonnethead shark, other derived androgens may have important functions in growth, maturation, and reproduction. J. Exp. Zool. 284:595-603, 1999.
Assuntos
20-alfa-Di-Hidroprogesterona/sangue , Androstenos/sangue , Prenhez/fisiologia , Tubarões/sangue , Testosterona/análogos & derivados , Animais , Cromatografia Líquida de Alta Pressão , Copulação/fisiologia , Di-Hidrotestosterona/sangue , Estradiol/sangue , Feminino , Masculino , Gravidez , Progesterona/sangue , Radioimunoensaio , Caracteres Sexuais , Maturidade Sexual/fisiologia , Testosterona/sangueRESUMO
In general, growth hormone acts as a factor promoting cell proliferation in the positive direction and suppresses apoptosis. No report has described growth hormone (GH)-induced structural luteolysis. The present studies showed that GH induced structural luteolysis in rats after the induction of functional luteolysis by treatment with bromocriptine, and that apoptotic cells were present among luteal cells during structural luteolysis as shown by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Zymography showed that the activity of matrix metalloproteinase (MMP)-2 increased during GH-induced structural luteolysis. The expression of c-myc protein of luteal cells was significantly decreased, but proliferating cell nuclear antigens (PCNA) were conversely increased during structural luteolysis, as shown by Western blot analysis. We propose that an excessive increase in PCNA and a marked decrease in c-myc protein of luteal cells lead to a disorder in the signals concerned with DNA synthesis, causing mitotic catastrophe and inducing apoptosis in luteal cells, and that structural luteolysis may be triggered. GH-induced apoptosis in structural luteolysis therefore highly depends on the cell cycle. There are thought to be two mechanisms of GH-induced structural luteolysis. One is apoptosis, and the other is destruction of extracellular matrix by MMP.
Assuntos
Corpo Lúteo/efeitos dos fármacos , Hormônio do Crescimento Humano/farmacologia , Superovulação , 20-alfa-Di-Hidroprogesterona/sangue , Animais , Apoptose/efeitos dos fármacos , Bromocriptina/farmacologia , Corpo Lúteo/citologia , Corpo Lúteo/metabolismo , Feminino , Gelatinases/metabolismo , Humanos , Luteólise/sangue , Luteólise/efeitos dos fármacos , Luteólise/metabolismo , Metaloproteinase 2 da Matriz , Metaloendopeptidases/metabolismo , Peso Molecular , Tamanho do Órgão/efeitos dos fármacos , Progesterona/sangue , Antígeno Nuclear de Célula em Proliferação/metabolismo , Proteínas Proto-Oncogênicas c-myc/metabolismo , Ratos , Ratos Sprague-DawleyRESUMO
Treatment of cyclic and pregnant rats with progesterone stimulates cell proliferation within the islets of Langerhans. It was investigated whether this effect of progesterone depends on sex and/or the presence of the gonads or the presence of oestradiol. For this purpose, Silastic tubes containing progesterone were inserted s.c. in intact and gonadectomized male and female rats, and in gonadectomized female rats treated with oestradiol. After 6 days of progesterone treatment, rats were infused for 24 h with 5-bromo-2'-deoxyuridine (BrdU) and dividing cells were identified in pancreatic sections by immunostaining for BrdU. Progesterone treatment increased islet-cell proliferation in intact male and female rats (P < 0.05), but not in gonadectomized male and female rats or in gonadectomized female rats supplemented with oestradiol. Furthermore, in intact male and female rats, progesterone treatment also stimulated cell proliferation in extra-islet pancreatic tissue (P < 0.05). Identification of the proliferating cells, by double-immunocytochemistry, revealed that progesterone treatment stimulated proliferation of both alpha and beta cells within the pancreatic islets. In extra-islet pancreatic tissue, progesterone treatment stimulated proliferation in both duct (cytokeratin 20-immunoreactive) and non-duct cells. Progesterone treatment did not increase the number of single glucagon or insulin-containing cells outside the pancreatic islets, nor that of cytokeratin 20/insulin double-positive cells, suggesting that progesterone treatment did not stimulate differentiation of duct cells into endocrine cells. Progesterone treatment did not affect insulin responses to an i.v. glucose load (0.5 g/kg body weight). It is concluded that progesterone stimulates pancreatic cell proliferation indirectly; gonadal factor(s), not identical to oestradiol, is (are) probably involved.
Assuntos
Estradiol/farmacologia , Ilhotas Pancreáticas/efeitos dos fármacos , Progesterona/farmacologia , 20-alfa-Di-Hidroprogesterona/sangue , Animais , Glicemia/análise , Bromodesoxiuridina/química , Divisão Celular/efeitos dos fármacos , Estradiol/sangue , Feminino , Teste de Tolerância a Glucose/veterinária , Imuno-Histoquímica , Insulina/sangue , Ilhotas Pancreáticas/citologia , Ilhotas Pancreáticas/fisiologia , Masculino , Orquiectomia/veterinária , Ovariectomia/veterinária , Gravidez , Progesterona/sangue , Radioimunoensaio/veterinária , Ratos , Ratos WistarRESUMO
A reversed-phase HPLC method previously developed for the analysis of progesterone and its major metabolites has been transferred successfully to a capillary electrochromatography (CEC) system. Procedures for fabricating packed capillaries and the modifications made to the capillary electropherograph which allow operation in the CEC mode without pressurisation are described. The dependence of electroosmotic flow on electric field strength, pH and organic modifier content is discussed. Direct comparison with HPLC shows that CEC provides useful gains in efficiency and speed of analysis and requires vastly reduced amounts of both chromatographic phases and material for analysis. On-line concentration is described which allows the lower sensitivity of CEC to be offset by injecting analytes from a non-eluting solution. Examination of steroids in plasma demonstrates that the superior separation by CEC is maintained in a complex biological matrix.
Assuntos
Cromatografia Líquida de Alta Pressão , Cromatografia/métodos , Esteroides/sangue , 17-alfa-Hidroxiprogesterona/sangue , 20-alfa-Di-Hidroprogesterona/sangue , Acetonitrilas , Androstenodiona/sangue , Concentração de Íons de Hidrogênio , Metanol , Noretindrona/sangue , Progesterona/sangue , Sensibilidade e Especificidade , Solventes , Testosterona/sangueRESUMO
Somatolactin (SL) is a hormone recently isolated and characterized from fish pituitaries. Although the functions of SL are still largely unknown, it has been implicated in reproduction. In this study, the effects of gonadal steroids on SL secretion were investigated in Atlantic salmon male parr in two experiments. In both, mature males were gonadectomized in the autumn and implanted with Silastic capsules containing testosterone (T), 11-ketoandrostenedione (11kA), or 17 alpha,20 beta-dihydroxy-4-pregnene-3-one (20-P), gonadectomized alone, or sham-operated. In addition, immature males were implanted with T or 11kA in experiment 1. After 4-5 weeks pituitaries and plasma were sampled and SL levels measured by radioimmunoassay (RIA). Plasma levels of T, 11-ketotestosterone, and 20-P were also measured by RIA. In experiment 1, initial immature males had lower (0.7 +/- 0.4 ng/ml) plasma SL levels than initial mature males (3.3 +/- 0.4 ng/ml), whereas pituitary content was not influenced. Gonadectomy significantly reduced both plasma SL levels (experiment 1, sham controls 5.6 +/- 0.5 ng/ml, castrated 1.6 +/- 0.5 ng/ml; experiment 2, sham controls 6.5 +/- 1.1 ng/ml, castrated 3.3 +/- 0.4 ng/ml) and the pituitary content of SL (experiment 1, sham controls 1206 +/- 187 ng/pituitary, castrated 663 +/- 104 ng/pituitary; experiment 2, sham controls 1043 +/- 199 ng/pituitary, castrated 629 +/- 70 ng/pituitary), suggesting that the testes stimulated the synthesis and release of pituitary SL. Overall, the effects of steroid replacement were inconsistent between the experiments, although in experiment 2 castrated males receiving the highest dose of T had significantly higher plasma SL levels (8.2 +/- 1.2 ng/ml) than all other castrated groups (1.8-4.3 ng/ml).
Assuntos
Glicoproteínas/sangue , Orquiectomia , Hipófise/efeitos dos fármacos , Hormônios Hipofisários/sangue , Salmão/sangue , Esteroides/farmacologia , 20-alfa-Di-Hidroprogesterona/sangue , Análise de Variância , Androstenos/sangue , Animais , Proteínas de Peixes , Masculino , Hipófise/química , Salmão/cirurgia , Testosterona/sangueRESUMO
The objective of this study was to determine whether faecal progestagen measurement could be used to diagnose pregnancy in wild black rhinoceros cows. Immunoreactive 20alpha-progestagens were measured in faecal samples collected regularly (one or two times times per week) from pregnant and non-pregnant wild black rhinoceros females (n = 6) in Zimbabwe. Fresh dung piles deposited by the study animals were serially sampled during prolonged periods of tracking with local game scouts. Samples were stored frozen, and dried prior to methanol extraction. Immunoreactivity in faecal extracts was measured with a 20alpha-dihydroprogesterone enzyme immunoassay and was shown to reflect circulating progesterone concentrations. Mean concentrations of faecal 20alpha-progestagens during each month of gestation were significantly higher than faecal concentrations in non-pregnant animals (P<0.05), except during the second month of gestation. Faecal 20alpha-progestagens remained 5-10 times higher than concentrations in non-pregnant animals from the 4th to 15th month of gestation. It was concluded that regular non-invasive reproductive monitoring of black rhinoceros in the wild was possible and that pregnancy could be accurately diagnosed from the measurement of 20alpha-progestagens in faecal samples. The use of this technique in wild black rhinoceros populations will offer new perspectives for in situ management of this endangered species.
Assuntos
20-alfa-Di-Hidroprogesterona/análise , Fezes/química , Perissodáctilos , Testes de Gravidez/veterinária , 20-alfa-Di-Hidroprogesterona/sangue , Animais , Feminino , Idade Gestacional , Técnicas Imunoenzimáticas , Gravidez , Testes de Gravidez/métodos , Fatores de TempoRESUMO
20alpha-Hydroxysteroid dehydrogenase (20alpha-HSD, E.C.1.1.1.149) in rat luteal tissue, which catalyzes conversion of progesterone to a biologically inactive steroid, 20alpha-hydroxypregn-4-ene-3-one (20alpha-OHP), suppresses progesterone secretion into the circulation. An increase in 20alpha-HSD activity in luteal tissue in rats is a prerequisite for functional corpus luteum regression. This study was undertaken to find a steroid inhibitor for ovarian cytosolic 20alpha-HSD activity among derivatives based on progesterone structure. A derivative designated as STZ26 (D-homo-16-oxa-4-androstene-3,16alpha-dione) was found to inhibit potently 20alpha-HSD activity in cultured luteal cells. Ovarian 20alpha-HSD activity consists of two isoforms (HSD1 and HSD2). Kinetic analyses of STZ26 for HSD1 and HSD2 showed that the compound suppressed only HSD1 activity by competitive inhibition. Pseudopregnant rats were treated with STZ26 from 13 to 19 days after cervical stimulation. Either an elevation of peripheral 20alpha-OHP levels or a concomitant depletion of peripheral progesterone levels at the end of pseudopregnancy was considerably inhibited in treated animals, although not completely. The results showed that STZ26 is a biologically active inhibitor for HSD1 activity in the luteal tissue and suggested that the depletion of progesterone levels toward the end of pseudopregnancy is not solely due to the elevation of HSD1 activity.